Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2001, p. 2518-2524, Vol. 39, No. 7
Department of Pathology, School of
Medicine,1 and Institute of Human
Virology,2 University of Maryland,
Baltimore, Maryland; Medical Research Foundation of Trinidad
and Tobago, Port of Spain, Trinidad,3 and
Princess Margaret Hospital, Nassau, Bahamas4
Received 27 November 2000/Returned for modification 28 March
2001/Accepted 2 May 2001
The VIDAS HIV DUO Ultra, a fourth-generation immunoassay under
development for the simultaneous detection of human immunodeficiency virus type 1 (HIV-1) p24 antigen and antibodies to HIV-1 and HIV-2, was
evaluated. The enzyme-linked fluorescence immunoassay, performed on the
automated VIDAS instrument, is claimed to detect early and established
HIV infection. The assay was challenged with a total of 2,847 samples
that included 74 members of 10 seroconversion panels, 9 p24
antigen-only-reactive members of a panel of group M clades, 503 consecutively collected samples from individuals seeking care in the
University of Maryland Medical System, 1,010 samples from U.S. blood
donors, 1,141 samples from patients in a high-incidence population in
Trinidad, 83 samples from a clinic for sexually transmitted diseases in
the Bahamas, 10 confirmed HIV-1 group O samples, and 16 confirmed HIV-2
samples from the Cote d'Ivoire. Reference tests were U.S. Food and
Drug Administration-licensed HIV antibody screening, p24 antigen tests,
HIV confirmatory assays, and the Roche Diagnostics Amplicor HIV-1
Monitor. The VIDAS HIV DUO Ultra demonstrated 100% sensitivity and
99.5% specificity overall, with a 99.7% specificity in low-risk
individuals. The analytical sensitivity, as assessed by seroconversion
panels and p24 antigen in samples, was equivalent to the sensitivity of
the reference assays used to characterize these panels. The VIDAS HIV
DUO Ultra is accurate, offers potential advantages over conventional HIV testing for time and cost savings, has walk-away capability, and
correctly identifies both early and established HIV infections.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.7.2518-2524.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Fourth-Generation Enzyme-Linked Immunosorbent Assay
for the Simultaneous Detection of Human Immunodeficiency Virus
Antigen and Antibody
*
Corresponding author. Mailing address: University of
Maryland, 725 W. Lombard St. #515, Baltimore, MD 21201. Phone: (410) 750-1721. Fax: (410) 706-2789. E-mail:
saviller{at}umbi.umd.edu.
This article has been cited by other articles:
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»